New AI Tools for Efficient Billing and Enhanced Testing

New Healthcare AI Tools

The integration of artificial intelligence into health IT vendor offerings for provider operations, medical testing, patient engagement, and various other use cases has led to a remarkable pace of innovation in the industry.

AI-Powered Billing Assistants

Seattle-based Healthtech company, established in 2021, made an announcement on Tuesday regarding the expansion of its cloud-powered AI Application for physician. The new addition includes generative AI capabilities that aim to enhance human talent and alleviate the burden on billing specialists.

The company is dedicated to relieving the burdens of administrative work throughout the healthcare revenue cycle. Their mission is to develop tools that effectively reduce administrative costs, boost productivity, and enhance the overall daily job experience for healthcare professionals.

In a recent announcement, the founder and CEO of Healthtech company highlighted the truly staggering amount of time that medical billing teams spend on the phone with payers.

He emphasized that it is common for medical billing teams to dedicate two-thirds of their day to this task, which not only hampers productivity but also negatively impacts job satisfaction and performance.

Healthtech leader states that PayerVA’s virtual agents efficiently handle various tasks, such as navigating payer interactive voice response systems, enduring hold times, and communicating with human representatives. These agents meticulously document information, taking comprehensive notes, and utilize GPT technology to generate narrative call and transaction summaries.

Our AI virtual agents are trained to handle routine phone-based tasks, allowing human talent to concentrate on strategic activities and enhance productivity,” stated the founder and CEO of Healthtech company.

The cofounder and CTO of the start-up studio, emphasized that the generative AI agents effectively emulate the process of experienced billing team members in creating narratives, ensuring adherence to the same stringent standards. Additionally, he highlighted the significance of leveraging Microsoft Azure for highly secure and HIPAA-compliant operations while utilizing the capabilities of GPT. He stated, “This is crucial for any company serving the healthcare industry, particularly considering that the business associate agreement mandated under HIPAA is not available when using GPT directly through OpenAI.”

Since the launch of its claims platform, the company has introduced a range of new capabilities, including prior authorizations and denials management, further enhancing their offerings.

miRNA Signatures: A Promising Tool for Early Cancer Detection

Ovarian cancer has long posed a significant challenge in terms of early detection, contributing to its high fatality rate.

As part of an exclusive licensing agreement, a leading medical equipment company have partnered with Boston-based research institute to design and develop a noninvasive miRNA-based test. This innovative test will utilize circulating microRNAs, either independently or in combination with proteins or other factors, to identify ovarian cancer in women with adnexal masses.

In an announcement on Thursday, the president and CEO of a Healthcare technology company stated, “The addition of this new non-invasive, molecular-based risk assessment tool to our portfolio represents a significant advancement in equipping physicians with valuable information for determining the appropriate treatment approach.”

The company’s ovarian cancer risk assessment portfolio will incorporate this new test. It combines noninvasive blood-based tests for initial clinical assessment of ovarian cancer risk in women with benign or indeterminate adnexal masses, along with FDA-cleared products that detect the risk of ovarian malignancies planned for surgery.

AI Powered Personalized Oncology Advisor

Belong.Life, a provider of patient engagement and community platforms, has introduced Dave, an AI oncology mentor designed to offer a higher level of support to cancer patients and their families.

In an announcement on Wednesday,  expressed, “The introduction of Belong’s AI oncology mentor, Dave, signifies a significant milestone in our mission to revolutionize the healthcare industry.”

Dave delivers intelligent, personalized, and readily accessible information instantly, thereby potentially enhancing the quality of care and life for millions of patients worldwide.

As a large language model trained on patient-physician and patient-to-patient interaction data from Belong’s Beating Cancer Together app, Dave utilizes natural language processing techniques. It has been rigorously tested by over 10,000 cancer patients.

Dave is capable of providing comprehensive and empathetic responses tailored to the challenges faced by cancer patients. Furthermore, it retains a long-term memory of previous conversations, enabling continuous communication across multiple chat sessions, ensuring a seamless user experience.

Belong’s Beating Cancer Together app offers free access to Dave, the AI oncology mentor. Additionally, it is available as a customizable software-as-a-service (SaaS) solution for hospitals, healthcare providers, and patient support programs. This allows providers to incorporate their own in-house clinical guidelines for exclusive and optimized utilization.

Leave A Comment

New Healthcare AI Tools

Health IT vendors are increasingly integrating artificial intelligence into their offerings for provider operations, medical testing, patient engagement, and other use cases, resulting in a rapid pace of innovation.

AI-Powered Billing Assistants

The Seattle-based Outbound AI, founded in 2021, announced Tuesday it has expanded its cloud-powered PayerVA Console with generative AI that “augments human talent” while reducing billing specialist burden.

The company says that its mission is to remove the burdens of administrative work across the healthcare revenue cycle and create tools that lower administrative costs, improve productivity and elevate “the daily job experience.”

The amount of time medical billing teams spend on the phone with payers is truly staggering, Stead Burwell, founder and CEO of Outbound AI, said in the announcement.

“It can easily be two-thirds of their day. This is not only counterproductive, but it’s degrading to job satisfaction and performance,” he said.

PayerVA’s virtual agents navigate payer interactive voice response systems, wait on hold and speak to human representatives, according to Outbound AI. They take “comprehensive notes” and by leveraging GPT, produce narrative call and transaction summaries.

“Our AI virtual agents are specially trained to handle routine phone-based tasks so human talent can be more strategic and get more done,” Burwell said.

The generative AI agents simulate how experienced billing team members create narratives and are held to the same standards, explained Jonathan Wiggs, cofounder and CTO of the start-up incubated at Madrona Venture Labs.

“We’re not only capitalizing on the capabilities of GPT, we’re doing so in a highly secure, HIPAA-compliant manner through Microsoft Azure,” he added.

“This is crucial for any company that serves the healthcare industry, especially considering the business associate agreement mandated under HIPAA is not available if using GPT directly through OpenAI.”

Since launching its claims platform, a series of new capabilities, including prior authorizations and denials management, has been added.

miRNA Signatures: A Promising Tool for Early Cancer Detection

Ovarian cancer is highly lethal in part because of how difficult it has historically been to diagnose.

Aspira Women’s Health’s has signed an exclusive licensing agreement with Boston-based Dana-Farber Cancer Institute for the design and development of a noninvasive miRNA-based test that will utilize circulating microRNAs – either alone or in conjunction with proteins or other factors – to identify ovarian cancer in women with adnexal masses.

“Adding this new non-invasive, molecular-based risk assessment tool to our portfolio will be another significant step forward in arming physicians with information to determine an appropriate treatment pathway,” said Nicole Sandford, president and CEO, in Thursday’s announcement.

According to the company, the new test will be part of the company’s ovarian cancer risk assessment portfolio, which combines noninvasive blood-based tests for use in the initial clinical assessment of ovarian cancer risk in women with benign or indeterminate adnexal masses with the use of FDA-cleared products that detect the risk of ovarian malignancies planned for surgery.

Dipanjan Chowdhury, codeveloper and chief of the Division of Radiation and Genome Stability at DFCI added, “This technique may help address a significant unmet diagnostic need in ovarian cancer with a non-invasive, easy, fast and affordable diagnostic.”

AI Powered Personalized Oncology Advisor

According to Belong.Life, a provider of patient engagement and community platforms, Dave brings a new level of support to cancer patients and their families.

“Belong’s AI oncology mentor, Dave, marks a significant milestone in our journey to revolutionize the health industry,” said Eliran Malki, cofounder and CEO, in Wednesday’s announcement.

“Dave provides smart, personalized and accessible information instantaneously, which can greatly improve the quality of care and life for millions of patients worldwide.”

Dave is a large language model that also uses natural language processing trained on patient-physician and patient-to-patient interaction data aggregated from Belong’s Beating Cancer Together app and tested by more than 10,000 cancer patients.

It can provide oncology-specific, comprehensive and empathetic answers to cancer patients’ challenges. Dave also retains a long-term memory of previous correspondence, allowing continuous communication across multiple chat sessions, according to the company.

It’s available free to users on Belong’s Beating Cancer Together app and also available as a customizable SaaS solution for hospitals, providers and patient support programs. Providers can include in-house clinical guidelines for their optimal and exclusive use.

Reference: https://www.healthcareitnews.com/news/vendor-notebook-new-ai-tools-cut-billing-burdens-improve-testing-and-more

Leave A Comment

x

Request a Free Quote

    Enter the Captcha: captcha

    0